Compare EPR Properties (EPR) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EPR Properties vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? EPR Properties trades at $54.79 (market cap $4.18B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and EPR Properties pays a 6.82% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EPR Properties for 48 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| EPR | IONS | |
|---|---|---|
Market Cap | $4.18B | $7.10B |
Volume | 699,137 | 2,027,457 |
Sector | Real Estate | Health |
52-Week High | $64.32 | $86.50 |
52-Week Low | $48.71 | $42.38 |
Typical Hold Time | 48 Days | 0 Days |
Enterprise Value | $7.69B | $6.66B |
Dividend Yield | 6.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EPR Properties trades at $54.80, down 1.1% today, with a bearish technical signal and mixed earnings history. The REIT maintains strong profitability with 37.66% net income margin and 10.31% ROE, supported by a 6.5% dividend yield. Recent news highlights EPR's diversification into theme parks and fitness, with Q3 2026 earnings scheduled for October 29, 2026.
Analyst consensus targets $65.50 (31.8% upside) with 7 Buy ratings, though technicals suggest near-term pressure. Risks include rising Treasury yields compressing REIT valuations and Q1 2026 earnings miss. The stock offers value at 17.5x P/E but faces headwinds from interest rate sensitivity.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
